Drugs / Alvogyl
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06823544 | Feb → Jul 2025 overdue | alveolar periostitis | HITEC-Institute of Medical Sciences | Not yet recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06144983 | Feb → Sep 2022 | impacted teeth, multiple | University of Baghdad | Completed | No outcome recorded |
| Phase 4 | NCT03402321 | Apr → Jun 2019 | — | Karim ehab gerges | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06456060 Comparator | Jun → Dec 2024 overdue | alveolar periostitis | Watim Medical & Dental College | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alvogyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06144983 ↗ |
| Route | Other | “was inserted inside the alveolus” NCT06144983 ↗ |